Bone Cells, collectively known as osteocytes, osteoblasts, and osteoclasts, are integral to the dynamic process of bone remodeling and maintenance. Osteoblasts, responsible for bone formation, produce the extracellular matrix and mineralize it, contributing to bone strength and structure. As bone matures, some osteoblasts transform into osteocytes, which are embedded in the bone matrix and play a vital role in mechanosensing and signaling. Osteoclasts, on the other hand, are involved in bone resorption, breaking down old or damaged bone tissue. This orchestrated activity of osteoblasts, osteocytes, and osteoclasts ensures the continuous renewal and adaptation of the skeletal system throughout life. Bone cells maintain bone homeostasis, responding to mechanical forces, hormonal signals, and systemic factors. Imbalances in bone cell activity can lead to conditions such as osteoporosis, where bone density decreases, or osteopetrosis, characterized by abnormally dense bones. Understanding the molecular and cellular mechanisms of bone cells is crucial for developing treatments for bone disorders and advancing regenerative therapies. Research in bone cell biology explores the complex interactions that govern bone remodeling, offering insights into the maintenance of skeletal health and the development of innovative interventions for bone-related conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy